Concenter BioPharma
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jerusalem, IsraelWebsite
www.concenterbiopharma.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Concenter BioPharma
Concenter BioPharma is a biopharmaceutical company focused on developing novel, first-in-class drugs for the treatment and prevention of Type 2 Diabetes. Utilizing a core technology platform, the company has created a family of non-steroidal chemical complexes that have demonstrated efficacy and safety in clinical applications. Their innovative drug, which acts through three synergistic mechanisms, aims to restore insulin resistance and address various complications associated with diabetes. Targeting a global patient population of approximately 570 million, Concenter BioPharma is committed to advancing its pipeline through expedited regulatory pathways.Explore more
Concenter BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Concenter BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Concenter BioPharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Concenter BioPharma has new funding data
Product Launch: Get notified when Concenter BioPharma launches new products
Concenter BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Concenter BioPharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Concenter BioPharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Concenter BioPharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Concenter BioPharma
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Concenter BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Concenter BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Concenter BioPharma.
Concenter BioPharma Tech Stack
A closer look at the technologies used by Concenter BioPharma
Concenter BioPharma News & Media
OG Acquisition 2 Corp. Announces Advancement of Concenter BioPharma Clinical Trials and Progress Toward A Public Listing
VANCOUVER, BC, CANADA, January 12, 2026 /EINPresswire.com/ -- OG Acquisition 2 Corp. (“OG” or the “Company”) today announced a significant milestone in its previously disclosed letter of intent (“LOI”) with Concenter BioPharma (“Concenter”), as Concenter …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Concenter BioPharma
Sign Up For FreeTo access detailed company insights
Concenter BioPharma is a biopharmaceutical company focused on developing novel, first-in-class drugs for the treatment and prevention of Type 2 Diabetes. Utilizing a core technology platform, the company has created a family of non-steroidal chemical complexes that have demonstrated efficacy and safety in clinical applications. Their innovative dru... Read More
